PortfoliosLab logo
XBIO vs. XBIT
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between XBIO and XBIT is 0.12, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


Performance

XBIO vs. XBIT - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Xenetic Biosciences, Inc. (XBIO) and XBiotech Inc. (XBIT). The values are adjusted to include any dividend payments, if applicable.

-100.00%-90.00%-80.00%-70.00%-60.00%December2025FebruaryMarchAprilMay
-99.58%
-86.07%
XBIO
XBIT

Key characteristics

Sharpe Ratio

XBIO:

-0.38

XBIT:

-0.82

Sortino Ratio

XBIO:

-0.13

XBIT:

-1.23

Omega Ratio

XBIO:

0.98

XBIT:

0.85

Calmar Ratio

XBIO:

-0.26

XBIT:

-0.75

Martin Ratio

XBIO:

-1.39

XBIT:

-1.50

Ulcer Index

XBIO:

19.06%

XBIT:

44.75%

Daily Std Dev

XBIO:

69.54%

XBIT:

80.93%

Max Drawdown

XBIO:

-99.94%

XBIT:

-92.67%

Current Drawdown

XBIO:

-99.92%

XBIT:

-89.72%

Fundamentals

Market Cap

XBIO:

$4.27M

XBIT:

$89.02M

EPS

XBIO:

-$2.57

XBIT:

-$1.26

PEG Ratio

XBIO:

0.00

XBIT:

0.00

PS Ratio

XBIO:

1.71

XBIT:

12.23

PB Ratio

XBIO:

0.71

XBIT:

0.49

Total Revenue (TTM)

XBIO:

$2.64M

XBIT:

$867.00K

Gross Profit (TTM)

XBIO:

$2.64M

XBIT:

$432.00K

EBITDA (TTM)

XBIO:

-$4.04M

XBIT:

-$38.71M

Returns By Period

In the year-to-date period, XBIO achieves a -21.30% return, which is significantly higher than XBIT's -29.37% return. Over the past 10 years, XBIO has underperformed XBIT with an annualized return of -44.08%, while XBIT has yielded a comparatively higher -16.29% annualized return.


XBIO

YTD

-21.30%

1M

36.40%

6M

-14.21%

1Y

-18.44%

5Y*

-19.15%

10Y*

-44.08%

XBIT

YTD

-29.37%

1M

-11.43%

6M

-66.18%

1Y

-69.67%

5Y*

-27.23%

10Y*

-16.29%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

XBIO vs. XBIT — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

XBIO
The Risk-Adjusted Performance Rank of XBIO is 2929
Overall Rank
The Sharpe Ratio Rank of XBIO is 3131
Sharpe Ratio Rank
The Sortino Ratio Rank of XBIO is 3333
Sortino Ratio Rank
The Omega Ratio Rank of XBIO is 3434
Omega Ratio Rank
The Calmar Ratio Rank of XBIO is 3535
Calmar Ratio Rank
The Martin Ratio Rank of XBIO is 1111
Martin Ratio Rank

XBIT
The Risk-Adjusted Performance Rank of XBIT is 99
Overall Rank
The Sharpe Ratio Rank of XBIT is 1010
Sharpe Ratio Rank
The Sortino Ratio Rank of XBIT is 1010
Sortino Ratio Rank
The Omega Ratio Rank of XBIT is 1111
Omega Ratio Rank
The Calmar Ratio Rank of XBIT is 88
Calmar Ratio Rank
The Martin Ratio Rank of XBIT is 88
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

XBIO vs. XBIT - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Xenetic Biosciences, Inc. (XBIO) and XBiotech Inc. (XBIT). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


The current XBIO Sharpe Ratio is -0.38, which is higher than the XBIT Sharpe Ratio of -0.82. The chart below compares the historical Sharpe Ratios of XBIO and XBIT, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio-1.00-0.500.000.501.00December2025FebruaryMarchAprilMay
-0.27
-0.86
XBIO
XBIT

Dividends

XBIO vs. XBIT - Dividend Comparison

Neither XBIO nor XBIT has paid dividends to shareholders.


TTM2024202320222021
XBIO
Xenetic Biosciences, Inc.
0.00%0.00%0.00%0.00%0.00%
XBIT
XBiotech Inc.
0.00%0.00%0.00%0.00%22.46%

Drawdowns

XBIO vs. XBIT - Drawdown Comparison

The maximum XBIO drawdown since its inception was -99.94%, which is greater than XBIT's maximum drawdown of -92.67%. Use the drawdown chart below to compare losses from any high point for XBIO and XBIT. For additional features, visit the drawdowns tool.


-100.00%-95.00%-90.00%-85.00%-80.00%-75.00%-70.00%December2025FebruaryMarchAprilMay
-99.91%
-89.72%
XBIO
XBIT

Volatility

XBIO vs. XBIT - Volatility Comparison

The current volatility for Xenetic Biosciences, Inc. (XBIO) is 14.30%, while XBiotech Inc. (XBIT) has a volatility of 26.40%. This indicates that XBIO experiences smaller price fluctuations and is considered to be less risky than XBIT based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


10.00%15.00%20.00%25.00%30.00%35.00%40.00%45.00%December2025FebruaryMarchAprilMay
14.30%
26.40%
XBIO
XBIT

Financials

XBIO vs. XBIT - Financials Comparison

This section allows you to compare key financial metrics between Xenetic Biosciences, Inc. and XBiotech Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.005.00M10.00M15.00M20212022202320242025
648.82K
867.00K
(XBIO) Total Revenue
(XBIT) Total Revenue
Values in USD except per share items